Borrelia burgdorferi disrupts gut barrier functions and microbiota–antibody interactions
Authors:
- Shilpa SachanSSShilpa Sachan
- Giang Vu Vi TranGTGiang Vu Vi Tran
- Kimberly J. OlsenKOKimberly J. Olsen
- Heather KulagaHKHeather Kulaga
- Anne DayADAnne Day
- Hannah P. SavageHSHannah P. Savage
- Alison W. RebmanARAlison W. Rebman
- John N. AucottJAJohn N. Aucott
- Isabel A. JimenezIJIsabel A. Jimenez
- Cory F. BraytonCBCory F. Brayton
- Nicole BaumgarthNBNicole Baumgarth
Open Access
- 24 August 2026
- journal article
- Published by Rockefeller University Press in Journal of Experimental Medicine
- Vol. 223 (9)
Abstract
Lyme disease, an emerging tickborne disease caused by Borrelia burgdorferi (Bb), can result in myriad symptoms of unknown causes in humans. Here, we show that Bb rapidly disrupts the gastrointestinal immune barrier in infected mice, inducing a “leaky gut” syndrome, characterized by increased gut permeability, systemic endotoxemia, elevated LPS binding protein and intestinal fatty acid binding protein, and altered blood leukocyte profiles. Patients with acute Lyme disease showed similar blood changes that correlated with disease symptoms and liver function measurements and largely resolved after antibiotic treatment. Mechanistically, Bb infection triggered mild early inflammation in the small intestine and suppressed humoral immunity to the microbiota, resulting in reduced IgA coating of fecal microbes and decreased antimicrobial serum IgG, despite the increased gut permeability. These defects preceded shifts in later observed gut bacterial composition and short-chain fatty acid production. Together, our findings identify mucosal barrier dysfunction and impaired antimicrobial humoral immunity as potential drivers of Bb-induced disease.Keywords
Funding Information
- National Institutes of Health (R01 AI157007)
- National Institutes of Health (5T35 OD024982)
- National Institutes of Health (T32OD011089)
- National Institutes of Health (F32AI161850)
- Congressionally Directed Medical Research Programs (TB220074)
- Steven and Alexandra Cohen Foundation
- Global Lyme Alliance
- Bay Area Lyme Foundation
- National Institute of Allergy and Infectious Diseases
This publication has 53 references indexed in Scilit:
- Mouse Models for the Study of Borrelia burgdorferi InfectionCurrent Protocols, 2024
- Role of mucosal immunity and epithelial–vascular barrier in modulating gut homeostasisInternal and Emergency Medicine, 2023
- Impact of the gut microbiota on the immune system2022
- A selective antibiotic for Lyme diseaseCell, 2021
- The immune landscape of IgA induction in the gutSeminars in Immunopathology, 2021
- Gut microbiota shape B cell in health and disease settingsJournal of Leukocyte Biology, 2021
- The presenting characteristics of erythema migrans vary by age, sex, duration, and body locationInfection, 2021
- Experimental human endotoxemia as a model of systemic inflammationBiochimie, 2019
- The Gut–Brain Axis and the Microbiome: Mechanisms and Clinical ImplicationsClinical Gastroenterology and Hepatology, 2019
- IgG “Detoxes” the Intestinal MucosaCell Host & Microbe, 2015